Lipid alterations have been observed in blood and cerebrospinal fluid (CSF) of ALS patients and in a symptomatic mouse model of ALS overexpressing mutant human Cu/Zn-superoxide dismutase gene (SOD1G93A) [14], correlating with disease prognosis [15]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.